Stock Spotlight Archives - Page 208 of 383

WednesdayFeb 10, 2021 3:14 pm

QualityStocksNewsBreaks – United Medical Equipment Business Solutions Network Inc. Provides Antigen Rapid POC Test as part of Comprehensive COVID-19 Strategy

United Medical Equipment (“UME,” “UMEBSNI”) is committed to offering high-quality COVID-19 services, solutions and supplies. Among these, UME provides the CareStart(TM) COVID-19 Antigen Rapid POC test. The test can be administered by authorized laboratories and at the point of care by medical professionals to detect the presence of the SARS-CoV-2 nucleocapsid protein antigen. The innovative test features a 10-minute processing time and provides the capability to identify acute infection with 88.4% sensitivity and 100% specificity. A recent article discussing this reads, “The CareStart product is part of a UME’s comprehensive COVID-19 monitoring strategy, which was carefully designed with the assistance…

WednesdayFeb 10, 2021 3:03 pm

QualityStocksNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Anticipates ‘Breakout Year’ in 2021

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, expects to achieve important milestones in the year ahead. The company’s proprietary i/Blue Imaging System is designed to significantly enhance surgeons’ ability to visualize and remove cancer cells using blue light by combining advanced optics and light sensors with a contrast imaging agent. The system’s key feature is its adaptability to almost any scope already in use by hospitals and surgical centers. Despite the challenges of 2020, Imagin was able to transition its product from the development stage to manufacturing, contracting with FDA registered and ISO 13485:2016-certified manufacturer Lighthouse Imaging.…

WednesdayFeb 10, 2021 2:53 pm

QualityStocksNewsBreaks – InsuraGuest Technologies Inc. (TSXV: ISGI) (OTCQB: ISGIF) Poised as Insurtech Disrupts the Insurance Industry

InsuraGuest Technologies (TSXV: ISGI) (OTCQB: ISGIF) is positioned as technology has become a key factor and is generating significant changes in the insurance industry. The combination of insurance and technology (insurtech) is disrupting the insurance industry in its entirety, delivering better processes, efficiencies and customer experiences and new cost-saving solutions. A leader in the insurtech sector, InsuraGuest continues to expand its already impressive reach into multiple insurance markets. A recent article discussing this reads, “The company’s first target is the hospitality sector with intent to dominate what looks to be an incredibly lucrative segment. InsuraGuest Technologies’ latest landmark is the…

FridayFeb 05, 2021 3:25 pm

QualityStocksNewsBreaks – United Medical Equipment Business Solutions Network Inc. Delivers Essential Solutions During Ongoing Pandemic

United Medical Equipment (“UME,” “UMEBSNI”) continues to move quickly to address the unique testing needs created by the ongoing global pandemic. UMEBSNI is a trusted supplier of FDA-approved COVID-19 rapid antigen test kits as part of its efforts to provide essential services during the epidemic. The company’s COVID-19 IgG/IgM Rapid Test Cassette detects coronavirus antibodies that appear in the bloodstream of individuals infected with the virus within 10 minutes. In addition, the test can also indicate whether a person has protection against the coronavirus. A recent article discussing this reads, “Other features of the test include the following: FDA Emergency…

FridayFeb 05, 2021 3:14 pm

QualityStocksNewsBreaks – ev Transportation Services Inc. Eyes Exciting Opportunity Through Regional Purchasing Program

ev Transportation Services (“evTS”), a designer, developer and manufacturer of all-electric lightweight commercial vehicles and fleet management solutions, recently entered into an agreement with the metropolitan Boston-area Metropolitan Area Planning Council (“MAPC”) and the Greater Boston Police Council (“GBPC”) to offer its EVs for sale. Under the agreement, the company’s FireFly ESV all-electric commercial utility vehicles will be sold under the agencies’ Group Purchasing Program contract for 2021 within the 101 cities and towns of the metropolitan area. “We are excited to include an electric vehicle manufacturer (‘evTS’) from Massachusetts in an MAPC Public Works and Public Safety Cooperative Purchasing…

FridayFeb 05, 2021 3:04 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) Positioned Amid Growing Acceptance, Legalization of Psilocybin

Cybin (NEO: CYBN) is a mushroom life science company focused on the pharmaceutical development of psychedelic products. Cybin’s subsidiary Serenity Life Sciences is engaged in the research and development of psilocybin-based medications. Widely referred to as magic mushrooms, Psilocybin has had its share of bad press. However, the company is positioned as perceptions of this substance are beginning to change. A recent article discussing this reads, “Under the Controlled Substances Act, psilocybin is included with heroin and LSD as a Schedule I drug. According to the National Drug Intelligence Center, psilocybin serves no legitimate medical purpose in the United States.…

FridayFeb 05, 2021 2:51 pm

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Makes Significant Step in Commitment to Reestablish US REE Supply Chain

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a diversified uranium miner, recently finalized a three-year agreement with the Chemours Company (NYSE: CC) to obtain natural monazite ore, one of the world’s highest-grade rare earth element (“REE”) minerals. Under the agreement, Energy Fuels will receive a minimum of 2,500 tons per year of the mineral, which represents a significant step in UUUU’s commitment to be a leader in re-establishing a fully integrated U.S. REE supply chain. “With our announcement . . . Southeast Utah is fast becoming America’s clean energy and critical minerals hub. Our goal is to domestically produce the…

FridayFeb 05, 2021 2:41 pm

QualityStocksNewsBreaks – Why Hollywall Entertainment Inc. (HWAL) Is ‘One to Watch’

Hollywall Entertainment (OTC: HWAL), an innovative company that operates through various subsidiaries, maximizes rights to its content libraries comprised of music, film, television, software and games. Founded in 2009, the company owns exclusive and nonexclusive rights to market, manufacture and distribute music master recordings performed by multiple platinum-selling acts. A recent article discussing the company reads, “HWAL continues to expand its business enterprise to numerous city and state municipalities and government agencies throughout the country, including: Washington DC, New York, Virginia, Massachusetts, Pennsylvania, Texas and California, as well as within the Blackbelt regions of Alabama, Louisiana, Mississippi, Georgia and North…

ThursdayFeb 04, 2021 3:22 pm

QualityStocksNewsBreaks – CannAssist International Corporation (CNSC) Pioneers Promising CiBiDinol Technology

CannAssist (OTCQB: CNSC), a biotechnological pharmaceutical and wellness company, believes that its proprietary CiBiDinol technology will be a game-changer. According to a recent article, “the company believes that the amount of CBD needed to achieve the targeted therapeutic effects can be reduced significantly, resulting in reduced costs for both manufacturers and consumers.” CBD-based products “reduce inflammation while providing pain relief.” They are also the preferred option because they are “a gentler way to relieve pain and reduce inflammation,” unlike mainstream pharmaceuticals that have dangerous toxicity levels. CiBiDinol’s high efficacy per dose was the subject of “testing conducted via third-party services…

ThursdayFeb 04, 2021 3:00 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) on the Verge of Changing History with Berubicin

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, has set sights on an encouraging future for glioblastoma patients with its upcoming Phase 2 trial of Berubicin. The article detailing this groundbreaking news quoted the company’s CEO John Climaco as saying, “Anthracyclines as a class of chemotherapy have been used for over 60 years to treat a variety of cancers… However, historically, anthracyclines have never been used to treat primary or metastatic brain cancers because scientists could not demonstrate that anthracyclines were able…

Site Search

Company Search

Category: Stock Spotlight